Israel has begun testing a fourth dose of the Covid-19 vaccine in healthy patients as it intends to deploy an additional booster shot to at-risk populations. This is the first time in the world that healthy subjects have received the fourth dose of the Covid-19 vaccine, said Sheba Medical Center.
About 150 healthcare workers with reduced levels of antibodies were part of the trial at the Sheba Medical Center outside Tel Aviv.
Dr. Jacob Lavee, former director of the Heart Transplant Unit at Sheba Medical Center, told CNN: “I don’t feel as much as a guinea pig. “I volunteered for the study that was done here on previous injections, mainly booster shots, because I knew my immunity had dropped below the threshold, and therefore, I not only potentially exposed to Omicrons, which, more importantly, I could be a potential hazard to the heart transplant patients I am caring for.”
On December 21, Prime Minister Naftali Bennett welcomed the decision of an expert panel to recommend booster supplements for people over 60, healthcare workers and those with weakened immune systems. Translate. But the General Director of the Ministry of Health has not yet signed the promulgation.
“Great news, don’t waste time – get vaccinated,” Bennett said in a statement at the time.
Those eligible for the fourth dose will be given it as long as at least four months have passed since the third dose, the government said in the statement.
“The State of Israel continues to be at the forefront of the global effort to respond to the pandemic. Israeli citizens are the first in the world to receive the third dose of the COVID-19 vaccine and we are also continuing to pioneer the fourth dose,” added Bennett.
Initial results from the study are expected by the end of the week, when Israel’s growing Covid-19 load is likely to be even heavier.
Dr Gili-Regev Yochay, director of the Infection Prevention and Control Unit at Sheba Medical Center, told CNN: “I don’t think it’s true, right now but it could change in a week. “It depends on what we see happening in the UK, and also here – if we see more severe disease, it will probably be accurate. That’s why it’s important to start researching as soon as possible. ”